Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Shifting from a Rheumatologic Point of View toward Patient-centered Care in Rheumatoid Arthritis with an Integrated Management of Comorbidities.

Roubille C, Fesler P, Combe B.

J Rheumatol. 2019 Jun;46(6):545-547. doi: 10.3899/jrheum.181379. No abstract available.

PMID:
31154441
2.

sST2 as a New Biomarker of Chronic Kidney Disease-Induced Cardiac Remodeling: Impact on Risk Prediction.

Plawecki M, Morena M, Kuster N, Chenine L, Leray-Moragues H, Jover B, Fesler P, Lotierzo M, Dupuy AM, Klouche K, Cristol JP.

Mediators Inflamm. 2018 Oct 8;2018:3952526. doi: 10.1155/2018/3952526. eCollection 2018.

3.

High-frequency autonomic modulation: a new model for analysis of autonomic cardiac control.

Champéroux P, Fesler P, Judé S, Richard S, Le Guennec JY, Thireau J.

Br J Pharmacol. 2018 Aug;175(15):3131-3143. doi: 10.1111/bph.14354. Epub 2018 Jun 15.

4.

Relevance and feasibility of a systematic screening of multimorbidities in patients with chronic inflammatory rheumatic diseases.

Daïen CI, Tubery A, Beurai-Weber M, du Cailar G, Picot MC, Jaussent A, Roubille F, Cohen JD, Morel J, Bousquet J, Fesler P, Combe B.

Joint Bone Spine. 2019 Jan;86(1):49-54. doi: 10.1016/j.jbspin.2018.03.016. Epub 2018 Apr 11.

PMID:
29654949
5.

In-depth haemodynamic phenotyping of pulmonary hypertension due to left heart disease.

Gerges C, Gerges M, Fesler P, Pistritto AM, Konowitz NP, Jakowitsch J, Celermajer DS, Lang IM.

Eur Respir J. 2018 May 24;51(5). pii: 1800067. doi: 10.1183/13993003.00067-2018. Print 2018 May.

PMID:
29599186
6.

Evaluation of the sST2-guided optimization of medical treatments of patients admitted for heart failure, to prevent readmission: Study protocol for a randomized controlled trial.

Curinier C, Solecki K, Dupuy AM, Breuker C, Lotierzo M, Zerkowski L, Kalmanovich E, Akodad M, Adda J, Battistella P, Castet-Nicolas A, Kuster N, Marques S, Soltani S, Chettouh M, Verchere A, Belloc C, Roubille C, Fesler P, Mercier G, Cristol JP, Audurier Y, Roubille F.

Contemp Clin Trials. 2018 Mar;66:45-50. doi: 10.1016/j.cct.2018.01.007. Epub 2018 Feb 4. No abstract available.

PMID:
29414143
7.

Point-of-care creatinine testing in patients receiving contrast-enhanced computed tomography scan.

Bargnoux AS, Beaufils O, Oguike M, Lopasso A, Dupuy AM, Sebbane M, Badiou S, Fesler P, Cristol JP.

Clin Chim Acta. 2018 Mar;478:111-113. doi: 10.1016/j.cca.2017.12.025. Epub 2017 Dec 18.

PMID:
29269201
8.

Application of the 2015/2016 EULAR recommendations for cardiovascular risk in daily practice: data from an observational study.

Daïen CI, Tubery A, Cailar GD, Mura T, Roubille F, Morel J, Bousquet J, Fesler P, Combe B.

Ann Rheum Dis. 2018 Apr;77(4):625-626. doi: 10.1136/annrheumdis-2017-211074. Epub 2017 May 6. No abstract available.

PMID:
28478400
9.

Noninvasive evaluation of left ventricular elastance according to pressure-volume curves modeling in arterial hypertension.

Bonnet B, Jourdan F, du Cailar G, Fesler P.

Am J Physiol Heart Circ Physiol. 2017 Aug 1;313(2):H237-H243. doi: 10.1152/ajpheart.00086.2017. Epub 2017 May 5.

10.

Retinal vascular caliber associated with cardiac and renal target organ damage in never-treated hypertensive patients.

Daien V, Granados L, Kawasaki R, Villain M, Ribstein J, Du Cailar G, Mimran A, Fesler P.

Microcirculation. 2017 May;24(4). doi: 10.1111/micc.12344.

PMID:
27987377
11.

MACVIA-LR (Fighting Chronic Diseases for Active and Healthy Ageing in Languedoc-Roussillon): A Success Story of the European Innovation Partnership on Active and Healthy Ageing.

Bousquet J, Bourret R, Camuzat T, Augé P, Bringer J, Noguès M, Jonquet O, de la Coussaye JE, Ankri J, Cesari M, Guérin O, Vellas B, Blain H, Arnavielhe S, Avignon A, Combe B, Canovas G, Daien C, Dray G, Dupeyron A, Jeandel C, Laffont I, Laune D, Marion C, Pastor E, Pélissier JY, Galan B, Reynes J, Reuzeau JC, Bedbrook A, Granier S, Adnet PA, Amouyal M, Alomène B, Bernard PL, Berr C, Caimmi D, Claret PG, Costa DJ, Cristol JP, Fesler P, Hève D, Millot-Keurinck J, Morquin D, Ninot G, Picot MC, Raffort N, Roubille F, Sultan A, Touchon J, Attalin V, Azevedo C, Badin M, Bakhti K, Bardy B, Battesti MP, Bobia X, Boegner C, Boichot S, Bonnin HY, Bouly S, Boubakri C, Bourrain JL, Bourrel G, Bouix V, Bruguière V, Cade S, Camu W, Carre V, Cavalli G, Cayla G, Chiron R, Coignard P, Coroian F, Costa P, Cottalorda J, Coulet B, Coupet AL, Courrouy-Michel MC, Courtet P, Cros V, Cuisinier F, Danko M, Dauenhauer P, Dauzat M, David M, Davy JM, Delignières D, Demoly P, Desplan J, Dujols P, Dupeyron G, Engberink O, Enjalbert M, Fattal C, Fernandes J, Fouletier M, Fraisse P, Gabrion P, Gellerat-Rogier M, Gelis A, Genis C, Giraudeau N, Goucham AY, Gouzi F, Gressard F, Gris JC, Guillot B, Guiraud D, Handweiler V, Hayot M, Hérisson C, Heroum C, Hoa D, Jacquemin S, Jaber S, Jakovenko D, Jorgensen C, Kouyoudjian P, Lamoureux R, Landreau L, Lapierre M, Larrey D, Laurent C, Léglise MS, Lemaitre JM, Le Quellec A, Leclercq F, Lehmann S, Lognos B, Lussert CM, Makinson A, Mandrick K, Mares P, Martin-Gousset P, Matheron A, Mathieu G, Meissonnier M, Mercier G, Messner P, Meunier C, Mondain M, Morales R, Morel J, Mottet D, Nérin P, Nicolas P, Nouvel F, Paccard D, Pandraud G, Pasdelou MP, Pasquié JL, Patte K, Perrey S, Pers YM, Portejoie F, Pujol JL, Quantin X, Quéré I, Ramdani S, Ribstein J, Rédini-Martinez I, Richard S, Ritchie K, Riso JP, Rivier F, Robine JM, Rolland C, Royère E, Sablot D, Savy JL, Schifano L, Senesse P, Sicard R, Stephan Y, Strubel D, Tallon G, Tanfin M, Tassery H, Tavares I, Torre K, Tribout V, Uziel A, Van de Perre P, Venail F, Vergne-Richard C, Vergotte G, Vian L, Vialla F, Viart F, Villain M, Viollet E, Ychou M, Mercier J.

J Frailty Aging. 2016;5(4):233-241.

PMID:
27883170
12.

[Living Lab MACVIA. Chronic diseases].

Avignon A, Fesler P, Daien C, Costa D, Picot MC, Roubille F, Sultan A, Viarouge-Reunier C, Attalin V, Badin M, Boegner C, Demoly P, Dauzat M, David M, Lognos B, Morel J, Pasquié JL, Ribstein J, Granier S, Combe B, Mercier J, Bourret R, Bousquet J.

Presse Med. 2015 Nov;44 Suppl 1:S47-54. doi: 10.1016/j.lpm.2015.07.009. Epub 2015 Oct 23. French. No abstract available.

PMID:
26476755
13.

Markers of bone remodeling are associated with arterial stiffness in renal transplanted subjects.

Bargnoux AS, Vetromile F, Kuster N, Barberet J, Dupuy AM, Ribstein J, Mourad G, Cristol JP, Fesler P.

J Nephrol. 2015 Dec;28(6):765-72. doi: 10.1007/s40620-015-0201-5. Epub 2015 Apr 29.

PMID:
25920618
14.

Arterial stiffness: an independent determinant of adaptive glomerular hyperfiltration after kidney donation.

Fesler P, Mourad G, du Cailar G, Ribstein J, Mimran A.

Am J Physiol Renal Physiol. 2015 Mar 15;308(6):F567-71. doi: 10.1152/ajprenal.00524.2014. Epub 2015 Jan 7.

15.

Prevalence and risk factors of noncontrolled and resistant arterial hypertension in renal transplant recipients.

Vetromile F, Pernin V, Szwarc I, Garrigue V, Delmas S, Mourad G, Fesler P.

Transplantation. 2015 May;99(5):1016-22. doi: 10.1097/TP.0000000000000467. Erratum in: Transplantation. 2016 Sep;100(9):e54.

PMID:
25393160
16.

Evaluation of five immunoturbidimetric assays for urinary albumin quantification and their impact on albuminuria categorization.

Bargnoux AS, Barrot A, Fesler P, Kuster N, Badiou S, Dupuy AM, Ribstein J, Cristol JP.

Clin Biochem. 2014 Nov;47(16-17):250-3. doi: 10.1016/j.clinbiochem.2014.07.014. Epub 2014 Jul 26.

PMID:
25072511
17.

[Left ventricular function in hypertension without left ventricular hypertrophy: echographic study with modelisation of left ventricular-aortic coupling].

Bonnet B, Jourdan F, du Cailar G, Mimran A, Fesler P.

Ann Cardiol Angeiol (Paris). 2014 Jun;63(3):120-3. doi: 10.1016/j.ancard.2014.05.012. Epub 2014 Jun 7. French.

PMID:
24952676
18.

Left ventricular mass changes after renal transplantation: influence of dietary sodium and change in serum uric acid.

du Cailar G, Oudot C, Fesler P, Mimran A, Bonnet B, Pernin V, Ribstein J, Mourad G.

Transplantation. 2014 Jul 27;98(2):202-7. doi: 10.1097/TP.0000000000000043.

PMID:
24926832
19.

Malnutrition and retinal vascular caliber in the elderly: the POLA study.

Daien V, Carriere I, Kawasaki R, Cristol JP, Villain M, Fesler P, Ritchie K, Delcourt C; POLA Study Group.

Invest Ophthalmol Vis Sci. 2014 May 27;55(7):4042-9. doi: 10.1167/iovs.13-13721.

PMID:
24867580
20.

Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies.

Bousquet J, Jorgensen C, Dauzat M, Cesario A, Camuzat T, Bourret R, Best N, Anto JM, Abecassis F, Aubas P, Avignon A, Badin M, Bedbrook A, Blain H, Bourdin A, Bringer J, Camu W, Cayla G, Costa DJ, Courtet P, Cristol JP, Demoly P, de la Coussaye JE, Fesler P, Gouzi F, Gris JC, Guillot B, Hayot M, Jeandel C, Jonquet O, Journot L, Lehmann S, Mathieu G, Morel J, Ninot G, Pelissier J, Picot MC, Radier-Pontal F, Robine JM, Rodier M, Roubille F, Sultan A, Wojtusciszyn A, Auffray C, Balling R, Barbara C, Cambon-Thomsen A, Chavannes NH, Chuchalin A, Crooks G, Dedeu A, Fabbri LM, Garcia-Aymerich J, Hajjam J, Melo Gomes E, Palkonen S, Piette F, Pison C, Price D, Samolinski B, Schunemann HJ, Sterk PJ, Yiallouros P, Roca J, Van de Perre P, Mercier J.

Curr Pharm Des. 2014;20(38):5928-44. Review.

PMID:
24641234
21.

Effect of early stage kidney disease on cardiac mass: comparison to post-donation renal function.

Rugale C, Du Cailar G, Fesler P, Ribstein J, Mourad G, Mimran A.

Am J Nephrol. 2013;38(2):168-73. doi: 10.1159/000353931. Epub 2013 Aug 7.

PMID:
23941801
22.

Retinal vascular caliber is associated with cardiovascular biomarkers of oxidative stress and inflammation: the POLA study.

Daien V, Carriere I, Kawasaki R, Cristol JP, Villain M, Fesler P, Ritchie K, Delcourt C.

PLoS One. 2013 Jul 26;8(7):e71089. doi: 10.1371/journal.pone.0071089. Print 2013.

23.

Validation of a new standardized cystatin C turbidimetric assay: evaluation of the three novel CKD-EPI equations in hypertensive patients.

Obiols J, Bargnoux AS, Kuster N, Fesler P, Piéroni L, Badiou S, Dupuy AM, Ribstein J, Cristol JP.

Clin Biochem. 2013 Oct;46(15):1542-7. doi: 10.1016/j.clinbiochem.2013.05.056. Epub 2013 May 29.

PMID:
23726805
24.

Retinal vascular caliber is associated with renal function in apparently healthy subjects.

Daien V, Kawasaki R, Villain M, Ribstein J, Du Cailar G, Mimran A, Fesler P.

Acta Ophthalmol. 2013 Jun;91(4):e283-8. doi: 10.1111/aos.12094. Epub 2013 Feb 14.

25.

Etanercept normalises left ventricular mass in patients with rheumatoid arthritis.

Daïen CI, Fesler P, du Cailar G, Daïen V, Mura T, Dupuy AM, Cristol JP, Ribstein J, Combe B, Morel J.

Ann Rheum Dis. 2013 Jun;72(6):881-7. doi: 10.1136/annrheumdis-2012-201489. Epub 2012 Aug 7.

PMID:
22872022
26.

Visual acuity outcome and predictive factors after bevacizumab for central retinal vein occlusion.

Daien V, Navarre S, Fesler P, Vergely L, Villain M, Schneider C.

Eur J Ophthalmol. 2012 Nov-Dec;22(6):1013-8. doi: 10.5301/ejo.5000162. Epub 2012 May 6.

PMID:
22569812
27.

Occlusion pressure analysis role in partitioning of pulmonary vascular resistance in CTEPH.

Toshner M, Suntharalingam J, Fesler P, Soon E, Sheares KK, Jenkins D, White P, Morrell NW, Naeije R, Pepke-Zaba J.

Eur Respir J. 2012 Sep;40(3):612-7. doi: 10.1183/09031936.00134111. Epub 2012 Feb 23.

28.

Acute pulmonary embolism decreases adenosine plasma levels in anesthetized pigs.

Kerbaul F, By Y, Gariboldi V, Mekkaoui C, Fesler P, Collart F, Brimioulle S, Jammes Y, Ruf J, Guieu R.

ISRN Cardiol. 2011;2011:750301. doi: 10.5402/2011/750301. Epub 2011 Apr 26.

29.

Treatment of hypertension with renin-angiotensin system inhibitors and renal dysfunction: a systematic review and meta-analysis.

Daien V, Duny Y, Ribstein J, du Cailar G, Mimran A, Villain M, Daures JP, Fesler P.

Am J Hypertens. 2012 Jan;25(1):126-32. doi: 10.1038/ajh.2011.180. Epub 2011 Oct 13. Review.

PMID:
21993366
30.

[Rheumatoid arthritis: a cardiovascular disease?].

Daïen CI, Fesler P.

Ann Cardiol Angeiol (Paris). 2012 Apr;61(2):111-7. doi: 10.1016/j.ancard.2011.07.008. Epub 2011 Aug 17. Review. French.

PMID:
21885031
31.

Early detection of isolated left ventricular diastolic dysfunction in high-risk differentiated thyroid carcinoma patients on TSH-suppressive therapy.

Taillard V, Sardinoux M, Oudot C, Fesler P, Rugale C, Raingeard I, Renard E, Ribstein J, du Cailar G.

Clin Endocrinol (Oxf). 2011 Nov;75(5):709-14. doi: 10.1111/j.1365-2265.2011.04138.x.

PMID:
21645022
32.

Prolonged overcirculation-induced pulmonary arterial hypertension as a cause of right ventricular failure.

Rondelet B, Dewachter C, Kerbaul F, Kang X, Fesler P, Brimioulle S, Naeije R, Dewachter L.

Eur Heart J. 2012 Apr;33(8):1017-26. doi: 10.1093/eurheartj/ehr111. Epub 2011 May 23.

PMID:
21606077
33.

Hypertonic saline hydroxyethylstarch restores right ventricular-arterial coupling after normovolemic hemodilution in piglets.

Kerbaul F, Rondelet B, Bénas V, Grisoli D, De Waroquier A, Fesler P, Fusai T, Brimioulle S.

Anesthesiology. 2011 Jul;115(1):136-43. doi: 10.1097/ALN.0b013e31821bdb69.

PMID:
21587062
34.

Estimation of glomerular filtration rate: what are the pitfalls?

Fesler P, Mimran A.

Curr Hypertens Rep. 2011 Apr;13(2):116-21. doi: 10.1007/s11906-010-0176-5. Review.

PMID:
21207252
35.

Dietary sodium, aldosterone, and left ventricular mass changes during long-term inhibition of the renin-angiotensin system.

du Cailar G, Fesler P, Ribstein J, Mimran A.

Hypertension. 2010 Nov;56(5):865-70. doi: 10.1161/HYPERTENSIONAHA.110.159277. Epub 2010 Oct 4.

PMID:
20921428
36.

Glomerular hemodynamics and arterial function in normal individuals.

Fesler P, du Cailar G, Ribstein J, Mimran A.

J Hypertens. 2010 Dec;28(12):2462-7. doi: 10.1097/HJH.0b013e32833e2a21.

PMID:
20720500
37.

Sildenafil added to sitaxsentan in overcirculation-induced pulmonary arterial hypertension.

Rondelet B, Dewachter L, Kerbaul F, Dewachter C, Hubloue I, Fesler P, Franck S, Remmelink M, Brimioulle S, Naeije R.

Am J Physiol Heart Circ Physiol. 2010 Oct;299(4):H1118-23. doi: 10.1152/ajpheart.00418.2010. Epub 2010 Aug 6.

38.

Early right ventriculo-arterial uncoupling in borderline pulmonary hypertension on experimental heart failure.

Pagnamenta A, Dewachter C, McEntee K, Fesler P, Brimioulle S, Naeije R.

J Appl Physiol (1985). 2010 Oct;109(4):1080-5. doi: 10.1152/japplphysiol.00467.2010. Epub 2010 Aug 5.

39.

Activation of apoptotic pathways in experimental acute afterload-induced right ventricular failure.

Dewachter C, Dewachter L, Rondelet B, Fesler P, Brimioulle S, Kerbaul F, Naeije R.

Crit Care Med. 2010 Jun;38(6):1405-13. doi: 10.1097/CCM.0b013e3181de8bd3.

PMID:
20431484
40.

Early high pulse pressure is associated with graft dysfunction and predicts poor kidney allograft survival.

Vetromile F, Szwarc I, Garrigue V, Delmas S, Fesler P, Mimran A, Ribstein J, Mourad G.

Transplantation. 2009 Nov 15;88(9):1088-94. doi: 10.1097/TP.0b013e3181ba1585.

PMID:
19898204
41.

[Moderate impairment of renal function and cardiovascular risk].

Fesler P, Ribstein J.

Rev Med Interne. 2009 Jul;30(7):585-91. doi: 10.1016/j.revmed.2008.10.018. Epub 2009 May 17. Review. French.

PMID:
19447528
42.

Microalbuminuria in type 2 diabetes and hypertension: a marker, treatment target, or innocent bystander?

Basi S, Fesler P, Mimran A, Lewis JB.

Diabetes Care. 2008 Feb;31 Suppl 2:S194-201. doi: 10.2337/dc08-s249. Review. No abstract available.

PMID:
18227485
43.

Pulse pressure is an independent determinant of renal function decline during treatment of essential hypertension.

Fesler P, Safar ME, du Cailar G, Ribstein J, Mimran A.

J Hypertens. 2007 Sep;25(9):1915-20.

PMID:
17762657
44.

Effects of levosimendan on acute pulmonary embolism-induced right ventricular failure.

Kerbaul F, Gariboldi V, Giorgi R, Mekkaoui C, Guieu R, Fesler P, Gouin F, Brimioulle S, Collart F.

Crit Care Med. 2007 Aug;35(8):1948-54.

PMID:
17568324
45.

Sitaxsentan for the prevention of experimental shunt-induced pulmonary hypertension.

Rondelet B, Kerbaul F, Vivian GF, Hubloue I, Huez S, Fesler P, Remmelink M, Brimiouille S, Salmon I, Naeije R.

Pediatr Res. 2007 Mar;61(3):284-8.

PMID:
17314684
46.

Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure.

Kerbaul F, Rondelet B, Demester JP, Fesler P, Huez S, Naeije R, Brimioulle S.

Crit Care Med. 2006 Nov;34(11):2814-9.

PMID:
16971854
47.

[Management of renal hypertension].

Fesler P, Ribstein J.

Presse Med. 2006 Jun;35(6 Pt 2):1061-6. Review. French.

PMID:
16783273
48.

Effects of sildenafil on hypoxic pulmonary vascular function in dogs.

Fesler P, Pagnamenta A, Rondelet B, Kerbaul F, Naeije R.

J Appl Physiol (1985). 2006 Oct;101(4):1085-90. Epub 2006 Jun 15.

49.

[Pancreatic panniculitis with polyarthritis and pathological fracture].

Fesler P, Ambrozkiewicz M, du Cailar G, Mimran A, Ribstein J.

Presse Med. 2005 Sep 10;34(15):1109-10. French. No abstract available.

PMID:
16334891
50.

Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index.

Verhave JC, Fesler P, Ribstein J, du Cailar G, Mimran A.

Am J Kidney Dis. 2005 Aug;46(2):233-41.

PMID:
16112041

Supplemental Content

Loading ...
Support Center